ResMed Inc. focuses on sleep and respiratory care as a long-term growth story

ResMed Inc. (ISIN US7611521078) is a global medical technology company specializing in sleep apnea and respiratory care solutions for patients in the United States and worldwide. Its shares are closely tied to long-term trends in the prevalence of sleep-disordered breathing and chronic obstructive pulmonary disease, as well as broader demand for digital health tools.

The company develops and sells devices that help people breathe more easily at night, alongside software platforms that support physicians, homecare providers and payers. For investors, the mix of hardware sales and ongoing software and services revenue is a central element of the long-term story.

Sleep apnea and chronic respiratory care

ResMed Inc. focuses heavily on diagnosing and treating obstructive sleep apnea, a condition where a patient’s airway collapses repeatedly during sleep and can lead to serious cardiovascular and metabolic complications. Continuous positive airway pressure, or CPAP, and bilevel devices are core products used to keep the airway open and reduce symptoms such as snoring, daytime fatigue and fragmented sleep.

Beyond sleep apnea, the company addresses chronic respiratory conditions including COPD and other forms of chronic lung disease. Noninvasive ventilators and related accessories help patients maintain adequate ventilation in home and clinical settings, reducing the need for hospital stays and improving quality of life. This patient group often requires ongoing, long-duration support, which can translate into recurring demand for devices, masks and replacement components.

Business model and recurring revenue

ResMed Inc.’s business model combines the sale of durable medical equipment with recurring revenue from consumables and software. Devices such as CPAP machines and ventilators are typically complemented by masks, tubing and filters that must be replaced regularly. This creates an installed base that continues to generate follow-on orders over time.

In parallel, the company offers cloud-connected platforms that allow remote monitoring of therapy adherence and device performance. These digital tools can help clinicians adjust treatment plans more quickly and support payers and providers in managing large patient populations. Over the long term, such services can deepen relationships with customers and expand the share of revenue that comes from software and data-driven offerings.

Representative product: connected CPAP device

A representative product in ResMed Inc.’s portfolio is a connected CPAP device designed for the treatment of obstructive sleep apnea. These machines deliver a continuous flow of pressurized air through a mask, preventing the airway from collapsing during sleep. Modern devices often include built-in wireless connectivity, allowing usage data and key metrics to be transmitted to cloud-based platforms for analysis.

Through these systems, clinicians can view adherence information, check whether patients are using their devices as prescribed and identify technical issues that might affect therapy. Patients may also use companion apps to track their own sleep metrics, review nightly usage and receive coaching on improving their habits. This combination of hardware and software illustrates how ResMed Inc. integrates traditional medical devices with digital health to support outcomes-focused care.

ResMed Inc. stock and trading venue

ResMed Inc. is listed on a major U.S. stock exchange and its stock is traded in U.S. dollars. The company’s share price typically reflects expectations around demand for sleep and respiratory care equipment, adoption of cloud-connected platforms and broader sentiment toward medical technology and digital health companies. Over longer horizons, growth in the diagnosed sleep apnea population, aging demographics and expanding access to care can all influence investor views of the business.

Because the company operates in a regulated healthcare environment, factors such as reimbursement frameworks, clinical guidelines and technology standards also play a role in shaping how the market values its stock. Investors often compare ResMed Inc. with other medical device and health technology firms when assessing valuation, profitability and growth potential.

This article was generated automatically and technically reviewed before publication. Market prices, analyst data and company information are provided without warranty and may change at short notice. This content is for informational purposes only and is not investment, financial, legal or tax advice. It is not a recommendation to buy or sell any security. Investing in securities involves risk, including the possible loss of principal.